IDENTIFYING BIOMARKERS AND DISSECTING COMBINATORIAL SYNERGIES TO IMPROVE IMMUNE CHECKPOINT INHIBITOR RESPONSE IN BLADDER CANCER

$1,472,880FY2020Defense Health AgencyDOD

The Cleveland Clinic Foundation

Investigators